Infectious Disease Testing Using PCR for IVD
Market
Infectious Disease Testing Using PCR for IVD Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Infectious Disease Testing Using PCR for IVD Market Size and Growth
The infectious disease testing using PCR market in vitro diagnostics (IVD) is experiencing rapid growth due to rising infectious diseases and technological advancements. The market size is projected to reach approximately $XX billion by 2027, driven by increasing demand for accurate, rapid testing solutions and innovations in PCR technology.
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher
◍ BD
◍ Roche Diagnostics
◍ Merck
◍ Siemens Healthineers
◍ Hologic
◍ Abbott Laboratories
◍ BioMerieux
◍ Cepheid
◍ Bayer
◍ Sysmex
◍ Ortho Clinical Diagnostics
◍ Qiagen
◍ Codexis
◍ Bio-Rad Laboratories
◍ Oxford Nanopore
The infectious disease testing market using PCR is competitive, with key players like Thermo Fisher, Roche, and Abbott leading innovation and product development. These companies enhance market growth through advanced technologies, diverse test offerings, and strategic partnerships, contributing to increased testing efficiency and accessibility.
Sales Revenue (examples):
- Thermo Fisher: ~$30 billion
- Roche Diagnostics: ~$15 billion
- Abbott Laboratories: ~$43 billion
- BD: ~$20 billion
Request Sample Report
Market Segmentation
By Application
Hospitals
Laboratory
Other
Request Sample Report
By Product
Direct Detection
Indirect Detection
Market Growth
Request Sample Report
$ X Billion USD
